These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15794056)

  • 1. [Ovarian cancer after in vitro fertilization].
    Milenković V; Sparić R; Dokić M; Petković S; Atanacković J
    Srp Arh Celok Lek; 2004; 132(9-10):331-3. PubMed ID: 15794056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for infertility and risk of invasive epithelial ovarian cancer--a case report.
    Jeremic K; Gojnic M; Milenković V; Petković S; Stojnić J; Lazović G; Berisavac M; Jeremić J
    Clin Exp Obstet Gynecol; 2006; 33(3):190-1. PubMed ID: 17089588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
    Venn A; Watson L; Bruinsma F; Giles G; Healy D
    Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three cases of ovarian cancer after ovulation induction for infertility].
    Abboud J; Attieh E; Atallah D; Kessrouani A; Chaoul G
    Contracept Fertil Sex; 1997 Jan; 25(1):64-5. PubMed ID: 9064055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility drugs, reproductive strategies and ovarian cancer risk.
    Tomao F; Lo Russo G; Spinelli GP; Stati V; Prete AA; Prinzi N; Sinjari M; Vici P; Papa A; Chiotti MS; Benedetti Panici P; Tomao S
    J Ovarian Res; 2014; 7():51. PubMed ID: 24829615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer after successful ovulation induction: a case report.
    Hull ME; Kriner M; Schneider E; Maiman M
    J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.
    Kessous R; Davidson E; Meirovitz M; Sergienko R; Sheiner E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):287-93. PubMed ID: 26337160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer and fertility medications: a critical appraisal.
    Kashyap S; Davis OK
    Semin Reprod Med; 2003 Feb; 21(1):65-71. PubMed ID: 12806561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction and ovarian malignancy.
    Beltsos AN; Odem RR
    Semin Reprod Endocrinol; 1996 Nov; 14(4):367-74. PubMed ID: 8988531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased odds of live birth in fresh in vitro fertilization cycles with shorter ovarian stimulation.
    Pereira N; Friedman C; Hutchinson AP; Lekovich JP; Elias RT; Rosenwaks Z
    Fertil Steril; 2017 Jan; 107(1):104-109.e2. PubMed ID: 27793370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
    Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
    Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian low malignant potential tumor: how to preserve fertility?].
    Koskas M; Madelenat P; Yazbeck C
    Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases.
    Unkila-Kallio L; Leminen A; Tiitnen A; Lehtovirta P; Wahlström T; Ylikorkala O
    Acta Obstet Gynecol Scand; 1997 Feb; 76(2):177-81. PubMed ID: 9049294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ASSISTED REPRODUCTIVE TECHNOLOGIES AND OVARIAN CANCEROGENESIS].
    Totev T; Tihomirova T; Tomov S; Gorchev G
    Akush Ginekol (Sofiia); 2016; 55(2):42-4. PubMed ID: 27509657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fertilization and breast cancer risk: a review.
    Salhab M; Al Sarakbi W; Mokbel K
    Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
    Gadducci A; Guerrieri ME; Genazzani AR
    Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility drugs and ovarian cancer.
    Artini PG; Fasciani A; Cela V; Battaglia C; de Micheroux AA; D'Ambrogio G; Genazzani AR
    Gynecol Endocrinol; 1997 Feb; 11(1):59-68. PubMed ID: 9086341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.